Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

European Heart Journal

Volumn 26, Issue 15, 2005, Pages 1461-1474

  Mahrholdt, Heiko ^a   Wagner, Anja ^b   Judd, Robert M ^b   Sechtem, Udo ^a   Kim, Raymond J ^b  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; CMR; Contrast enhancement; Delayed enhancement; MRI

Indexed keywords

ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; GADOLINIUM; GLYCERYL TRINITRATE;

ANGIOCARDIOGRAPHY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORONARY ARTERY SPASM; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FABRY DISEASE; HEART AMYLOIDOSIS; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ENHANCEMENT; MORPHOLOGY; MYOCARDIAL DISEASE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SCINTISCANNING; SURVIVAL; TISSUE CHARACTERIZATION; X RAY ANALYSIS;

CARDIOMYOPATHIES; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL ISCHEMIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 25444521252     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi258     Document Type: Review

References (51)

1. Richardson P, McKenna W, Bristow M. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-842.
2. Bender JR. Idiopathic dilated cardiomyopathy. An immunologic, genetic or infectious disease, or all of the above? Circulation 1991; 83:704.
3. Spirito P, Seidman CE, McKenna WJ. The management of hypertrophic cardiomyopathy. (Review). N Engl J Med 1997;336:775-785.
4. Felker GM, Thompson RE, Hare JM. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-1084.
5. Kubo N, Morimoto S, Hiramitsu S. Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy. Heart Vessels 1997;12: 167-170.
6. Simonetti OP, Kim RJ, Fieno DS. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223.
7. Mahrholdt H, Wagner A, Judd RM. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002; 23:602-619.
8. Ricciardi MJ, Wu E, Davidson CJ. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001;103:2780-2783.
9. Wagner A, Mahrholdt H, Holly T. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379.
10. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-218.
11. Bristow MR, Gilbert EM, Abraham WT. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996;94:2807-2816.
12. Wu E, Judd RM, Vargas J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28.
13. Bello D, Shah DJ, Farah GM. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-1953.
14. Schuster EH, Bulkley BH. Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients. Am Heart J 1980; 100:506-512.
15. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987;60: 1340-1355.
16. Koenig SH, Spiller M, Brown RD III. Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA). Magn Reson Med 1986;3:791-795.
17. Kim RJ, Judd RM, Chen EL. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation 1999;100:185-191
18. Rehwald WG, Fieno DS, Chen EL. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-229.
19. McCrohon JA, Moon JC, Prasad SK. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59.
20. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580.
21. Arroyo LH, Lee RT. Mechanisms of plaque rupture: mechanical and biologic interactions. JAMA 1999;281:921-926.
22. Choudhury L, Mahrholdt H, Wagner A. Myocardial scarring in minimally symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-2164.
23. Moon JCC, McKenna WJ, McCrohon JA. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-1567.
24. Wilson JM, Villareal RP, Hariharan R. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 2002;29:176-180.
25. Friedrich MG, Strohm O, Schulz-Menger J. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1809.
26. Mahrholdt H, Goedecke C, Wagner A. Cardiovascular magnetic resonance assessment of human myocarditis; a comparison to histology and molecular pathology. Circulation 2004;109:1250-1258.
27. Rochitte CE, Olivera PF, Joalbo M. Chagas disease is characterized by specific pattern and location of myocardial delayed enhanced MRI. (Abstract). J Cardiovasc Magn Reson 2003;5:115.
28. Kurashima K, Shimizu H, Ogawa H. MR and CT in the evaluation of sarcoid myopathy. J Comput Assist Tomogr 1991;15:1004-1007.
29. Vignaux O, Dhote R, Duboc D. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002;26:762-767.
30. Patel MR, Cawely PJ, Heitner JF. Improved diagnostic sensitivity of contrast enhanced cardiac MRI for cardiac sarcoidosis. (Abstract). Circulation 2004;108(Suppl.):645.
31. Sachdev B, Takenaka T, Teraguchi H. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002;105:1407-1411.
32. Moon JC, Sachdev B, Elkington AG. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-2155.
33. Maceira AM, Joshi J, Prasad SK. CMR in Amyloidosis. Circulation 2005;111:186-193.
34. Basso C, Thiene G, Corrado D. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 2000;31:988-998.
35. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979;43:1086-1102.
36. Maron BJ, Wolfson JK, Epstein SE. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-557.
37. Roberts CS, Roberts WC. Morphologic features. In: Zipes DP, Rowlands DJ, eds. Progress in Cardiology. Philadelphia: Lea & Febiger; 1989. p3-22.
38. Varnava AM, Elliott PM, Sharma S. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 2000;84:476-482.
39. Kuribayashi T, Roberts WC. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 1992;70:1333-1340.
40. Moon JC, Reed E, Sheppard MN. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 43:2260-2264.
41. Anderson KR, Sutton MG, Lie JT. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 1979;128:79-85.
42. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999;99:1091-1100.
43. Shirani J, Freant LJ, Roberts WC. Gross and semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy. Am J Cardiol 1993;72:952-957.
44. Patel MR, Heitner JF, Klem I. Presence and pattern of scar on delayed-enhanced MRI differentiates ischemic from non-ischemic cardiomyopathy. (Abstract). Circulation 2004;108(Suppl.):755.
45. Aretz HT, Billingham ME, Edwards WD. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
46. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-1245.
47. Klingel K, Stephan S, Sauter M. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol 1996;70:8888-8895.
48. Wagner A, Schulz-Menger J, Dietz R. Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA 2003; 16:17-20.
49. H. Mahrholdt, L Choudhury, A. Wagner. Relation of myocardial scarring to clinical risk factors for sudden cardiac death in hypertrophic cardiomyopathy. (Abstract) Circulation 2002;106(Suppl.):652.
50. Kim RJ Choi KM, Judd RM. Assessment of myocardial viability by contrast enhancement. In: Higgins CB, de Roos A, eds. Cardiovascular MRI and MRA. Philadelphia, PA: Lippincott Williams and Wilkins; 2003; 209-237.
51. Shah et al. In: Edelman RR, et al., eds. Clinical Magnetic Resonance Imaging, 3rd ed. New York: Elsevier Press; 2005.